Clinical Trial Update: Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-responders [Phase 4]

View source ↗

Summary

Phase 4 trial update examining ribavirin with sofusbuvir/velpatasvir/voxilaprevir for retreatment of chronic hepatitis C non-responders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Sofosbuvir/Velpatasvir/Voxilaprevir (sofosbuvir/velpatasvir/voxilaprevir)

Snippet

Sponsor: Helwan University | Conditions: Chronic Hepatitis C | Phase 4 | Status: COMPLETED